These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 9175313

  • 1. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
    Bacigalupo A, Piaggio G, Podestà M, Tong J, Pitto A, Figari O, Benvenuto F, Vassallo F, Tedone E, Grassia L, Van Lint MT, Gualandi F, Hoffman R.
    Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
    [Abstract] [Full Text] [Related]

  • 2. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A, Piaggio G, Podestá M, Raffo MR, Tedone E, Sogno G, Benvenuto F, Figari O, Grassia L, Bagnara GP.
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [Abstract] [Full Text] [Related]

  • 3. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G, Shao Z, Jia H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G, Aktan M, Diz-Küçükkaya R, Yavuz S, Nalçaci M, Oztürk S, Palanduz S, Doğan O, Ağan M.
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mechanism of immunosuppressive therapy for aplastic anemia].
    Teramura M, Saito H, Kobayashi S, Hoshino S, Oshimi K, Mizoguchi H.
    Rinsho Ketsueki; 1993 Mar; 34(3):273-6. PubMed ID: 7683063
    [Abstract] [Full Text] [Related]

  • 8. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 9. In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
    Cesana C, Carlo-Stella C, Mangoni L, Regazzi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V.
    Stem Cells; 1997 May; 15(3):207-13. PubMed ID: 9170212
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 15. Analysis of peripheral blood CD34+ cells mobilized with granulocyte colony-stimulating factor (G-CSF) using a long-term culture system.
    Suzuki T, Muroi K, Amemiya Y, Miura Y.
    Bone Marrow Transplant; 1998 Apr; 21(8):751-7. PubMed ID: 9603397
    [Abstract] [Full Text] [Related]

  • 16. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
    Matsuo Y, Iwanaga M, Mori H, Yoshida S, Kawaguchi Y, Yakata Y, Murata K, Nagai K, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M.
    Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
    [Abstract] [Full Text] [Related]

  • 17. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin: colony-stimulating activity and lymphokine production.
    Tong J, Bacigalupo A, Piaggio G, Figari O, Sogno G, Marmont A.
    Exp Hematol; 1991 Jun; 19(5):312-6. PubMed ID: 1902792
    [Abstract] [Full Text] [Related]

  • 18. Modified in vitro conditions for cord blood-derived long-term culture-initiating cells.
    Podestà M, Piaggio G, Pitto A, Zocchi E, Soracco M, Frassoni F, Luchetti S, Painelli E, Bacigalupo A.
    Exp Hematol; 2001 Mar; 29(3):309-14. PubMed ID: 11274758
    [Abstract] [Full Text] [Related]

  • 19. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [Abstract] [Full Text] [Related]

  • 20. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M, Nissen C, Manz CY, Toksoz D, Lyman SD, Wodnar-Filipowicz A.
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.